bromopyruvate has been researched along with Leishmaniasis, Diffuse Cutaneous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosentino-Gomes, D; da Silva, APP; Da Silva, D; Galina, A; Giarola, NLL; Gomes, MT; Gomes-Vieira, AL; Meyer-Fernandes, JR; Paes-Vieira, L; Sola-Penna, M | 1 |
1 other study(ies) available for bromopyruvate and Leishmaniasis, Diffuse Cutaneous
| Article | Year |
|---|---|
3-Bromopyruvate: A new strategy for inhibition of glycolytic enzymes in Leishmania amazonensis.
Topics: Animals; Blotting, Western; Brazil; Cricetinae; Humans; Leishmania mexicana; Leishmaniasis, Diffuse Cutaneous; Macrophages; Mice; Oxygen Consumption; Phosphopyruvate Hydratase; Pyruvates; RAW 264.7 Cells | 2021 |